中文 - EN
Home > News > Dr. Anjin Xianyu, Co-Founder and CTO of META Pharmaceuticals, Ranked on the 2022 Hurun U30 Chinese Entrepreneurial Pioneers List
Dr. Anjin Xianyu, Co-Founder and CTO of META Pharmaceuticals, Ranked on the 2022 Hurun U30 Chinese Entrepreneurial Pioneers List
2022/12/15


On December 15, 2022, the 2022 Hurun U30 China Entrepreneurial Pioneers List Conference convened in Panyu District, Guangzhou City, China. During this event, the Hurun Research Institute unveiled the 2022 Hurun U30 China Entrepreneurial Pioneers List (Hurun China Under30s 2022). This prestigious list aims to recognize entrepreneurial trailblazers in China who are under the age of 30 (including those who are 30 years old).

Among the distinguished honorees, Dr. Anjin Xianyu, co-founder and CTO of META Pharmaceuticals, was recognized for his outstanding contributions. META Pharmaceuticals, as a pioneer in the field of immune-metabolism drug discovery, remains committed to advancing therapeutic solutions for autoimmune diseases and beyond.

Dr. Anjin Xianyu, Co-Founder and CTO of META Pharmaceuticals

Dr. Anjin Xianyu, with a background in Biophysics and Systems Biology from the Weill Graduate School of Cornell University, USA, spearheads the visionary mission of META Pharmaceuticals. As the first commercialization company in China to deeply delve into the emerging field of immune metabolism, we are committed to developing first-in-class original drugs targeting this critical intersection.

Our founding team draws expertise from top research hospitals in the US, including Cornell University Medical College and the Memorial Sloan Kettering Cancer Center. This collective knowledge fuels our relentless pursuit of groundbreaking solutions for autoimmune diseases and beyond.

In June of this year, META Pharmaceuticals achieved a significant milestone by successfully completing its seed and Pre-A rounds of financing, totaling hundreds of millions of RMB. This strategic investment was led by Forcefield Ventures, XtalPi Inc., IMO Ventures, and Tiantu Capital.

Hurun Report (China’s top 100 richest people)

Hurun Hundred Fortune, an authoritative organization, meticulously tracks and documents the dynamic shifts within China’s entrepreneurial landscape. Founded by Rupert Hoogewerf in 1999, the Hurun Hundred Fortune List serves as a distinctive media platform. Its counterpart, the Hurun 100 Rich List, was conceived to “reveal the essence of China’s economic and social transformation.” This list celebrates the concept of “wealth heroes” while emphasizing the quality of wealth.

As one of the most influential rankings in the global business community, the Hurun U30 list stands out for its unique positioning, rigorous standards, independent authority, and high credibility. After rigorous selection processes, the Hurun U30 China Entrepreneurial Leaders list sheds light on emerging entrepreneurial trends. The inclusion of Dr. Fresh Yu, a trailblazer in the field of biomedicine, underscores the authoritative recognition of young entrepreneurs’ remarkable achievements. It also underscores the vigor and resilience of China’s youthful entrepreneurial spirit.

For over 20 years, Hurun Report has been committed to discovering the value of enterprises and promoting entrepreneurship through quality lists and research. The main coverage ranges from ‘Cradle of Wealth’ to ‘Hall of Wealth’. The ‘Cradle of Wealth’ is firstly the Most Wealthy Creative China Alumni Association, the role model of the Alumni Association is the U30, the role model of the U30 is the ‘Cheetah’ enterprises, the role model of the ‘Cheetah’ is the ‘Gazelle’ enterprises, the role model of ‘Gazelle’ is ‘Unicorn’, the role model of ‘Unicorn’ is China’s 500, and the role model of China’s top 500 is the world’s top 500. In this process, the entrepreneurs themselves from the 100 rich list to the global rich list, then to the charity list, etc., and finally complete the inheritance of wealth on the ‘Hall of Wealth’.